Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date

被引：0
|
作者：
Hodsman, AB
Hanley, DA
Josse, R
机构：
[1] Univ Western Ontario, St Josephs Hlth Ctr, Dept Med, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, Lawson Res Inst, London, ON N6A 4V2, Canada
[3] Univ Calgary, Fac Med, Div Endocrinol & Metab, Calgary, AB T2N 1N4, Canada
[4] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2002年 / 166卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1426 / 1430
页数：5
相关论文
共 50 条
  • [41] Osteosarcopenia: a risk factor for osteoporotic fractures
    Mastaglia, Silvina
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (03): : 357 - 365
  • [42] Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures
    Schwarcz, Yonatan
    Yanover, Chen
    Rouach, Vanessa
    Luria, Shai
    Goldshtein, Inbal
    OSTEOPOROSIS INTERNATIONAL, 2024, : 1839 - 1847
  • [43] Warfarin use and risk of osteoporotic fractures
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05): : 366 - 366
  • [44] Effect of Adherence on Lifetime Fractures in Osteoporotic Women Treated With Daily and Weekly Bisphosphonates
    Danese, Mark D.
    Badamgarav, Enkhe
    Bauer, Douglas C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (11) : 1819 - 1826
  • [45] Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates
    S. Ojeda-Bruno
    A. Naranjo
    F. Francisco-Hernández
    C. Erausquin
    I. Rúa-Figueroa
    J. C. Quevedo
    C. Rodríguez-Lozano
    Osteoporosis International, 2011, 22 : 1821 - 1828
  • [46] Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates
    Ojeda-Bruno, S.
    Naranjo, A.
    Francisco-Hernandez, F.
    Erausquin, C.
    Rua-Figueroa, I.
    Quevedo, J. C.
    Rodriguez-Lozano, C.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1821 - 1828
  • [47] Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidence
    Grassi, Giorgia
    Chiodini, Iacopo
    Palmieri, Serena
    Cairoli, Elisa
    Arosio, Maura
    Eller-Vainicher, Cristina
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (03) : 387 - 396
  • [48] Bisphosphonates do not reduce breast cancer in postmenopausal women
    Mathew, Aju
    Brufsky, Adam
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (02)
  • [49] Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
    Rabenda, V.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S19 - S20
  • [50] GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
    Hadji, P.
    Claus, V.
    Ziller, V.
    Intorcia, M.
    Kostev, K.
    Steinle, T.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 223 - 231
12345